Lv41
690 积分 2023-03-03 加入
New Trends in Brain Shuttle Peptides
3天前
已完结
Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization
13天前
已完结
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
13天前
已完结
Ensifentrine (Ohtuvayre™) for chronic obstructive pulmonary disease
21天前
已完结
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
24天前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
28天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
28天前
已完结
Faculty Opinions recommendation of Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures
29天前
已关闭
Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist
1个月前
已完结
Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology
1个月前
已完结
皖公网安备34019202002308
